Toward Patient-Centric Marketing
|
|
- Caitlin Gaines
- 6 years ago
- Views:
Transcription
1 20 May 2013 Vol. 12, No. 5 Pharma Marketing Network Toward Patient-Centric Marketing Working Effectively with Patient Groups Author: Miguel A. Tovar, (@blogaceutics on Twitter), Associate Manager and journalist at Contenidos e Información de Salud, S. L. (Barcelona, Spain) Published by: Pharma Marketing Network PO Box 760 Newtown, PA publisher@pharma-mkting.com PMN
2 Vol. 12, No. 5: May 20, 2013 p. 2 Part 1: Effective Ways of Working with Patient Groups I n his keynote speech at the eyeforpharma Barcelona 2013 conference, Keith Allan, head of global advocacy at Novartis, discussed working with patient advocacy groups and expressed his desire "to be seen as a part of the healthcare solution, engaging meaningfully with patient groups, instead of being seen as we were 20 years ago as a part of the problem". Allan recalled that "Nothing About Us Without Us!" was the motto of the European Cancer Patient Coalition established in "I think that motto represents the increasing power and importance that patient advocates inspired," he said. Evolution of Patient Advocacy Allan described the quick evolution of patient advocacy groups starting 20 to 30 years ago when patient associations were set up to support their members by providing health and advice. Then they became more sophisticated and capable and got involved in education and communications, particularly within the main therapeutic areas. At that time pharma realized that this was an opportunity for partnership to help in an ethical way with the education and training of patients. "But the big thing now that all we should be aware of is that now patient groups and patients are invited to the table to debate regulatory issues, political policy issues and in some cases reimbursement issues as well. So we have to take these people seriously, we have to involve them very early on in all our research programs, they need to be involved with us," he added. "Now they are part of the dialogue with health authorities, regulators, policy makers". In Allan s opinion, "there is a big gap between where we want to be and where we are now. He thinks that patient groups and patients are moving from being passive recipients of information and products to getting involved in disease management and the care of their own conditions. "So we have to take that seriously," he said. He believes that now is a time to go back to basics to look at things like trust, loyalty and sustainability when working with patient groups. "The growth of patient groups has increased 10-fold or 12-fold since the 2000, said Allan, thanks to the growing effectiveness of the patient movement. Now there are about 120,000 patient groups around the world," he estimated. "Patient groups are lobbying at the international level (UN, Brussels, WHO, etc.) and influencing the regulation of pharma activities, including reimbursement, providing services at the community level, and changing the framework within which the doctor works," he told the hundreds of delegates in the room. Characteristics of an Ideal Partnership Coping with legal restrictions regarding the information that can be communicated to patient groups, being accountable, and building up trust and consistency were the main challenges for the industry Allan said. Allan believes that the ideal partnership with patient organizations is based on finding a common agenda and treating each other as equals, being independent and being transparent. "The challenge is to get the balance right, getting to a point where we provide value to patients and patient advocates but complying with codes of integrity and conduct, said Allan. Understanding that challenge and regulating ourselves is very important. "The thing that most patient groups dislike intensely is constant change of contacts with the pharma representative, said Allan. For that reason he recommended that companies appoint one person to take on the responsibility rather than a multitude of people. This builds up trust and sustainability, he said. Meeting Patient Advocates Needs With regard to the most common needs of patient advocacy groups, Allan mentioned: help to become advocates and support to be better advocates; information about the new treatments; support for disease awareness initiatives. This must be done with transparency and compliance with the law. Allan referenced PatientView surveys as a good source of information about what patient groups expect from pharma. Many of the published results of these surveys confirned what Allan cited as important issues. According to the 2011 PatientView survey, the main factors about companies that affect reputation are: patient safety, adherence to the law, provision of high quality information to patients, having a patient-centered company strategy, high quality and useful products, transparency and ability to manage adverse news about products. On the other hand, the most important factors that promote patient groups to work with pharma are: trust, clarity, adherence to code of practice, mutual interest, treating each other as equals, and providing good feedback, and managing conflicts of interest.
3 Vol. 12, No. 5: May 20, 2013 p. 3 Declining Reputation A global PatientView survey was conducted at the end of 2012 to explore the views of 600 international, national, and regional patient groups from 56 countries. Patient group feedback provided rankings of 29 leading pharma companies for six key indicators that influence corporate reputation: patient-centeredness; patient information; patient safety; useful products; transparency; and integrity. The 2012 study was a repeat of a similar one carried out in See Figure 1, below. "There is no evidence at the moment that we are actually improving our relationship with these groups. In fact, it is deteriorating," Allan sadly admitted. "Our reputation is declining in the eyes of patient advocacy groups." PatientView defines corporate reputation as "the extent to which pharmaceutical companies are meeting the expectations of patients and patient groups. Only 34% of the patient groups responding to the 2012 survey stated that multinational pharma companies had an Excellent or Good reputation during the course of that year, compared with 42% in 2011 a 19% decline. When asked whether the corporate reputation of pharma had improved, declined, or remained unchanged in 2012, 40% of respondent patient groups stated that the reputation had declined (21% said it had improved). "So if we listen to our customer we are not meeting their expectations," Allan concluded. Figure 1. The performance of the pharma industry at important activities. How good or bad do you think the pharmaceutical industry is at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)? Source: PatientView Quarterly, January 2013, The Corporate Reputation of Pharma The Patient Perspective
4 Vol. 12, No. 5: May 20, 2013 p. 4 Strategic Recommendations Allan finished his presentation by providing three strategic recommendations. Companies need to: 1. avoid being overly product-focused in their relations with patient groups and have a robust patient centered strategy, 2. embrace patients and patient groups in any crisis management that they have to undertake, and 3. be more accessible to patient group partners. Part 2: Lundbeck s Patient-Centric Marketing Approach P utting in place a patient-centric marketing approach might prove a good strategy for a pharma company said Patrick J. Cashman, President and General Manager at Lundbeck Canada. He said this during his keynote presentation titled Lundbeck Adventures in Patient Centered Marketing on the second day of the eyeforpharma Barcelona 2013 conference. Lundbeck provides therapies for people with disorders of the central nervous system, e.g., in the area of depression, Alzheimer s Disease, and alcoholism. A patient-centric marketing approach helped Lundbeck to have the fastest growing product (Cipralex) and the fastest growing company in Canada for two years in a row. And they had similar success with Ebixa in Mexico. The idea of patient centric marketing is to keep the patient in line with everything you do, and that doesn't necessarily mean that the patient is controlling the therapeutic process, he said. He believes that this approach can help to improve the communication, the engagement of the patient and clinical outcomes. It helps to really understand the environment, the challenges that patients face, the perceptions of the world they are in. By improving understanding and outcomes, patients are more likely to stay on their treatments and use the product in a more appropriate manner. But supporting the patients is not enough. It is also necessary to support the relevant stakeholders. The family plays a key role in the patients' treatment outcomes, sometimes in a very positive manner and sometimes in a very negative manner, Cashman said. We want to make sure that the patients understand the medication and do what is right and we can play a leading role in influencing these stakeholders [physician, nurse, payer, pharmacy, family] to make sure that they also have the right information to help support the patient's treatment. Cashman also spoke about the patient journey, which he read about it on an article by Dr Simone Seiter, a consultant at IMS Health. The patient journey is every step of the way that the patient is going through from recognition of diagnosis of the disease through to the treatment and hopefully remission of the disease, he explained. Top Ten Pharma Performers Source: PatientView Quarterly, January 2013, The Corporate Reputation of Pharma The Patient Perspective Company Rank Rank Lundbeck 1 3 Gilead Sciences 2 10 Novartis 3 1 Janssen 4 - Pfizer 5 2 Abbott 6 8 Novo Nordisk 7 11 Roche 8 9 Lilly 9 18 GSK 10 4 Respondent patient groups ranked Lundbeck highly in 2012 for the quality of information that it has supplied to patients and for a good record on patient safety. There are very complicated and confusing journeys and there are many stages and emotions that patients pass through on their journey, noted Cashman. There may be misperceptions, there may be anger, there may be doubt and there may be denial. There may even be lack of awareness of the disease. We need to recognize what these patients are going through from their perspective, he said. One of the main goals throughout the journey is to make sure patients continue to take their medication as directed by their physicians. Cashman emphasized the importance of language for patient-centric communications. Our industry tends to use words that are very clinical and very data focused, he said. Our tradition has been to speak to clinicians and other healthcare providers. Now we all know that this has changed dramatically for the last few years and it continues to change. But if you are using a patientcentric marketing approach, you need to use language that patients understand and relate to, he emphasized.
5 Vol. 12, No. 5: May 20, 2013 p. 5 With regard to compliance, Cashman noted the obvious: if they feel better they don't feel they need it. They don't want to become addicted, or they don't like the secondary effects, or they don't feel the treatment is effective. To deal with this, Cashman emphasized the importance of not only our communications direct to patients, but also the communications we provide to healthcare professionals like doctors and nurses, who may be dealing with these questions and unknowns that the patients have. We need to help them to use patientcentric language and practices. Cashman believes that patient-centric marketing can help in terms of brand and company recognition, the uptake of the brand, adherence to the treatments that are offered, and improvement in value for patients, doctors and payers. It helps to focus all the activities on the patient, he concluded.
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (LATIN AMERICA EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (LATIN AMERICA EDITION) Feedback from 58 Latin-American patient groups PUBLISHED JUNE 2016 Que las Compañias Farmacéuticas tengan relación
More informationBELGIAN EU PRESIDENCY CONFERENCE ON RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMD)
BELGIAN EU PRESIDENCY CONFERENCE ON RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMD) Brussels, 19 October 2010 Summary Report Background and Objectives of the conference The Conference on Rheumatic and Musculoskeletal
More informationACHIEVING PATIENT-CENTRED COLLABORATIVE CARE (2008)
CMA POLICY ACHIEVING PATIENT-CENTRED COLLABORATIVE CARE (2008) The Canadian Medical Association (CMA) recognizes that collaborative care is a desired and necessary part of health care delivery in Canada
More informationPatient information and how patient advocacy can strengthen education and best practice
European CME Forum 2010 Patient information and how patient advocacy can strengthen education and best practice 1 Jan Geissler Founder and chair, Leukämie-Online e.v. Co-founder, CML Advocates Network
More informationPatient-Clinician Communication:
Discussion Paper Patient-Clinician Communication: Basic Principles and Expectations Lyn Paget, Paul Han, Susan Nedza, Patricia Kurtz, Eric Racine, Sue Russell, John Santa, Mary Jean Schumann, Joy Simha,
More informationPhase 2. Mental Health Matters St. Patrick s University Hospital
Phase 2 2010 Mental Health Matters St. Patrick s University Hospital Foreword St. Patrick s Hospital was founded by the vision and bequest of Jonathan Swift, Dean of St. Patrick s Cathedral. He saw, more
More informationKestrel House. A S Care Limited. Overall rating for this service. Inspection report. Ratings. Good
A S Care Limited Kestrel House Inspection report Kestrel House 14-16 Lower Brunswick Street Leeds West Yorkshire LS2 7PU Tel: 01132428822 Website: www.carewatch.co.uk Date of inspection visit: 31 May 2016
More informationProstate Cancer Activism and Education
Prostate Cancer Activism and Education A PRESENTATION AND WORKSHOP E. Michael D. ( Mike ) Scott Co-Founder and President, Prostate Cancer International What is Patient Education? A COMMONLY USED DEFINITION*
More informationIt s About the Conversation
Association of Spiritual Caregivers It s About the Conversation Faith Ambassador Program The name Honoring Choices Wisconsin is used under license from East Metro Medical Society Foundation. Plan ahead!
More informationEuropean Patients Academy on Therapeutic Innovation
European Patients Academy on Therapeutic Innovation http://www.patientsacademy.eu info@patientsacademy.eu The project is receiving support from the Innovative Medicines Initiative Joint Undertaking under
More informationNURS 147A NURSING PRACTICUM PSYCHIATRIC/MENTAL HEALTH NURSING CLINICAL EVALUATION CRITERIA. SAN JOSE STATE UNIVERSITY School of Nursing
SAN JOSE STATE UNIVERSITY School of Nursing NURS 147A - Nursing Practicum IVA - 2 Units Psychiatric/Mental Health Nursing Based on Scope and Standards of Psychiatric-Mental Health Nursing Practice (AP,
More informationSolent. NHS Trust. Allied Health Professionals (AHPs) Strategic Framework
Solent NHS Trust Allied Health Professionals (AHPs) Strategic Framework 2016-2019 Introduction from Chief Nurse, Mandy Rayani As the executive responsible for providing professional leadership for the
More informationResearch themes for the pharmaceutical sector
CENTRE FOR THE HEALTH ECONOMY Research themes for the pharmaceutical sector Macquarie University s Centre for the Health Economy (MUCHE) was established to undertake innovative research on health, ageing
More informationPractice Problems. Managing Registered Nurses with Significant PRACTICE GUIDELINE
PRACTICE GUIDELINE Managing Registered Nurses with Significant Practice Problems Practice Problems May 2012 (1/17) Mission The Nurses Association of New Brunswick is a professional regulatory organization
More informationA guide for Consumers MAKING MEDICAL DECISIONS FOR ANOTHER PERSON. Includes information about the form,
A guide for Consumers MAKING MEDICAL DECISIONS FOR ANOTHER PERSON Includes information about the form, 'What I understand to be the person s preferences and values' i This guide covers the following topics:
More informationReport extract: Integrated Delivery Networks in the US
Report extract: Integrated Delivery Networks in the US Payment Pressures: IDNs as a Solution insights and strategic recommendations: Healthcare delivery systems of all types are under financial pressures
More informationPatient Adherence & Engagement Summit 2009
6th Annual Patient Adherence & Engagement Summit 2009 Two Day Conference October 26-27 Crowne Plaza, Philadelphia, USA Benchmark your adherence strategies against our EXPERT SPEAKERS: Rich Baron Executive
More informationUnited BioSource Corporation: An Express Scripts Company
United BioSource Corporation: An Express Scripts Company Emerging Trends in Patient Engagement through Adherence and Compliance Programs Objectives Consider patient engagement across: cloud based platforms
More informationAdvance Care Planning Communication Guide: Overview
Advance Care Planning Communication Guide: Overview The INTERACT Advance Care Planning Communication Guide is designed to assist health professionals who work in Nursing Facilities to initiate and carry
More informationBig data in Healthcare what role for the EU? Learnings and recommendations from the European Health Parliament
Big data in Healthcare what role for the EU? Learnings and recommendations from the European Health Parliament Today the European Union (EU) is faced with several changes that may affect the sustainability
More informationCollaborative. Decision-making Framework: Quality Nursing Practice
Collaborative Decision-making Framework: Quality Nursing Practice SALPN, SRNA and RPNAS Councils Approval Effective Sept. 9, 2017 Please note: For consistency, when more than one regulatory body is being
More informationSupportive Care Roundtable
Supportive Care Roundtable Brussels, 20 February 2018 1 Preface Cancer supportive care is the prevention and management of the symptoms and side effects of cancer and its treatment across the cancer continuum
More informationarizona health net a better decision sm Putting you at the center of everything we do.
arizona health net a better decision sm Putting you at the center of everything we do. Nothing s more important than your health. When you re healthy, you want to stay healthy. When you re sick or have
More informationIntroduction. 3. The law gives the GMC four main functions:
Introduction GMC Response Public consultation on the future of electronic commerce and the implementation of the Directive on Electronic commerce (2000/31/EC) 5 November 2010 1. The General Medical Council
More informationMarine Corps Social Media Principles
Marine Corps Social Media Principles Defense Media Activity Marine Corps Element Marine Corps News Page 2 of 12 Throughout the Marine Corps history, people have discussed, debated and embraced the United
More informationNew Alignments in Data-Driven Care Coordination & Access for Specialty Products: Insights from the DIMENSIONS Report
New Alignments in Data-Driven Care Coordination & Access for Specialty Products: Insights from the DIMENSIONS Report Our Objectives By the end of the session, participants will understand: Evolving demands
More informationMeeting of the European Parliament Interest Group on Carers
Meeting of the European Parliament Interest Group on Carers Brussels, 20 October 2015 Meeting report Marian Harkin MEP opened the meeting with a special welcome to the visiting Irish carers group. She
More informationThe Vision for the Future
Project Destiny Executive Summary The American Pharmacists Association (APhA), the National Association of Chain Drug Stores (NACDS), and the National Community Pharmacists Association (NCPA) have joined
More informationManaging Privacy Risk in Your Research and Development Enterprise. Sujata Dayal, Abbott Justin McCarthy, Pfizer
Managing Privacy Risk in Your Research and Development Enterprise Sujata Dayal, Abbott Justin McCarthy, Pfizer Why Privacy Matters Human subject data is extremely sensitive Access to data is critical to
More information10 Things to Consider When Choosing a Home Care Agency
10 Things to Consider When Choosing a Home Care Agency Introduction Diminishing health and frailty are not popular topics of conversation for obvious reasons. But then these are not areas of life we can
More informationOur five year plan to improve health and wellbeing in Portsmouth
Our five year plan to improve health and wellbeing in Portsmouth Contents Page 3 Page 4 Page 5 A Message from Dr Jim Hogan Who we are What we do Page 6 Page 7 Page 10 Who we work with Why do we need a
More informationDoctors, Patients & Social Media
September, 2011 Doctors, Patients & Social Media Mary Modahl, Chief Communications Officer, QuantiaMD Lea Tompsett, Research Director, QuantiaMD Tracey Moorhead, President and Chief Executive Officer,
More informationRMI Researched Medicines Industry Association
RMI Researched Medicines Industry Association Submission to: Medsafe On the: Proposed Clinical Trials Guidelines 30 November 2009 Contact Kevin Sheehy, Scientific and Technical Manager RMI, Level 8, 86
More informationPursuing the Triple Aim: CareOregon
Pursuing the Triple Aim: CareOregon The Triple Aim: An Introduction The Institute for Healthcare Improvement (IHI) launched the Triple Aim initiative in September 2007 to develop new models of care that
More informationScotia College of Pharmacists Standards of Practice. Practice Directive Prescribing of Drugs by Pharmacists
Scotia College of Pharmacists Standards of Practice Practice Directive Prescribing of Drugs by Pharmacists September 2014 ACKNOWLEDGEMENTS This Practice Directives document has been developed by the Prince
More informationMonitoring the Mental Health Act 2015/16 SUMMARY
Monitoring the Mental Health Act 2015/16 SUMMARY Foreword The work of monitoring the Mental Health Act 1983 (MHA) is a distinct but supportive role to CQC s wider regulatory task. It is distinct, in part,
More informationSASKATCHEWAN ASSOCIATIO
SASKATCHEWAN ASSOCIATIO N Standards & Competencies for RN Specialty Practices Effective May 1, 2018 Table of Contents Background Introduction Requirements for RN Specialty Practices RN Procedures and RN
More informationAbbie Leibowitz, M.D., F.A.A.P, Health Advocate, Inc.
This Week In Medical Travel Today by Amanda Haar, Editor Volume 5, Issue 7 This week s issue is a good reminder of all factors affecting a consumer s choices for medical travel. The SPOTLIGHT interview
More informationA Journal of Rhetoric in Society. Interview: Transplant Deliberations and Patient Advocacy. Staff
Present Tense A Journal of Rhetoric in Society Interview: Transplant Deliberations and Patient Advocacy Staff Present Tense, Vol. 2, Issue 2, 2012. www.presenttensejournal.org editors@presenttensejournal.org
More informationHealth Technology Assessment (HTA) Good Practices & Principles FIFARMA, I. Government s cost containment measures: current status & issues
KeyPointsforDecisionMakers HealthTechnologyAssessment(HTA) refers to the scientific multidisciplinary field that addresses inatransparentandsystematicway theclinical,economic,organizational, social,legal,andethicalimpactsofa
More informationCEOCFO Magazine. Andy Reeves, RPh Chief Executive Officer OptiMed Specialty Pharmacy
CEOCFO Magazine ceocfointerviews.com All rights reserved! Issue: October 30, 2017 Q&A with Andy Reeves, RPh, CEO of OptiMed Specialty Pharmacy, a National Specialty and Infusion Pharmacy dedicated to Managing
More informationUNIT 4 ROLE OF NURSE IN COMMUNITY MENTAL HEALTH PROGRAMME
UNIT 4 ROLE OF NURSE IN COMMUNITY MENTAL HEALTH PROGRAMME Structure 4.0 Objectives 4.1 Introduction 4.2 Levels of Prevention and Role of a Nurse 4.2.1 Primary Prevention 4.2.2 Secondary Prevention 4.2.3
More informationGuidance For Health Care Staff Within NHS Grampian On Working With The Pharmaceutical Industry And Suppliers Of Prescribable Health Care Products
Title: Identifier: Guidance For Health Care Staff Within NHS Grampian On Working With The Pharmaceutical Industry And Suppliers Of Prescribable Health Care Products NHSG/guid/PharmInd/GMMG/738 Replaces:
More informationRPS in Scotland has had an influential year providing both written and oral evidence at the Scottish Parliament in a wide range of policy areas.
Speech by RPS President Ash Soni at the RPS Annual Conference 2017 3 September 2017 Thank you Paul and let me say how pleased I am as a member that you identified exactly the right areas where I and the
More informationAcceptance Speech. Writing Sample - Write. By K Turner
Acceptance Speech Thank you so much. Thank you to the committee for this recognition, thank you to the Texas Tech Administrators, and many thanks to my peer and friend who nominated me Jennifer Barnett.
More informationLiberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making
Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making Royal Pharmaceutical Society response The Royal Pharmaceutical Society (RPS) is the professional
More informationPatient-Centered Analytics Tools and technologies to enable patient centered insight
Patient-Centered Analytics Tools and technologies to enable patient centered insight Nina Mian, Head of Biomedical Informatics Advanced Analytics Center, AstraZeneca April 2015 The Advanced Analytics Centre
More informationConfronting the Challenges of Rare Disease:
Confronting the Challenges of Rare Disease: SOLUTIONS ACROSS THE ENTIRE PRODUCT LIFE CYCLE The Orphan Drug Act of 1983 brought increased awareness to the need for new treatments for rare disease patients
More informationPERSON CENTERED CARE PLANNING HONORING CHOICE WHILE MITIGATING RISK
PERSON CENTERED CARE PLANNING HONORING CHOICE WHILE MITIGATING RISK The purpose of the Rothschild Person-Centered Care Planning process is to support long term care communities in their efforts to honor
More informationA Specialist Palliative Care Nurses Competency Framework Helen Butler Education Team Leader Mercy Hospice Auckland
A Specialist Palliative Care Nurses Competency Framework Helen Butler Education Team Leader Mercy Hospice Auckland The aim of this session To refresh our memories about what a competency is To give a bit
More informationIslanders' Guide to the Mental Health Act
Community Legal Information Association of Prince Edward Island, Inc. Islanders' Guide to the Mental Health Act Prince Edward Island's Mental Health Act defines mental disorder as "a substantial disorder
More informationThis document applies to those who begin training on or after July 1, 2013.
Objectives of Training in the Subspecialty of Occupational Medicine This document applies to those who begin training on or after July 1, 2013. DEFINITION 2013 VERSION 1.0 Occupational Medicine is that
More informationCreating Stroke Systems of Care Elyas Bakhtiari, for HealthLeaders Magazine, June 9, 2010
Creating Stroke Systems of Care Elyas Bakhtiari, for HealthLeaders Magazine, June 9, 2010 If U.S. healthcare is headed toward a model that eliminates fragmentation and emphasizes continuity and cooperation,
More informationCase Study. Memorial Hermann Hospital System Healthcare
Case Study Memorial Hermann Hospital System Healthcare How one hospital system changed its entire culture from the ground up in order to become an award-winning, market-leading example of patient experience
More informationBASEL DECLARATION UEMS POLICY ON CONTINUING PROFESSIONAL DEVELOPMENT
UNION EUROPÉENNE DES MÉDÉCINS SPÉCIALISTES EUROPEAN UNION OF MEDICAL SPECIALISTS Av.de la Couronne, 20, Kroonlaan tel: +32-2-649.5164 B-1050 BRUSSELS fax: +32-2-640.3730 www.uems.be e-mail: uems@skynet.be
More informationReal World Evidence in Europe
Real World Evidence in Europe Jessamy Baird, RWE Director Madrid, 20 th October 2014. BEFORE I BEGIN; DISCLAIMERS: Dual perspective: Pharmaceutical: I work for Lilly, but this presentation represents my
More informationThe Future of Pharma: Patients Rising to the Core
The Future of Pharma: Patients Rising to the Core Jyotirmay Datta Vice President and Global Industry Head for Medical Devices, Wipro Limited Nitin Raizada GM, Industry Solutions Group, Lifesciences, Wipro
More informationCaring for Older People at Home
Social Work Research and Development Unit Caring for Older People at Home The Research The study: What did we do? We worked with four local authorities and 16 independent organisations from which they
More informationNursing Documentation 101
Nursing Documentation 101 Module 5: Applying Knowledge Part I Handout 2014 College of Licensed Practical Nurses of Alberta. All Rights Reserved. Nursing Documentation 101 Module 5: Applying Knowledge Part
More informationOBQI for Improvement in Pain Interfering with Activity
CASE SUMMARY OBQI for Improvement in Pain Interfering with Activity Following is the story of one home health agency that used the outcome-based quality improvement (OBQI) process to enhance outcomes for
More informationHigh Level Pharmaceutical Forum
High Level Pharmaceutical Forum 2005-2008 Final Conclusions and Recommendations of the High Level Pharmaceutical Forum On 2 nd October 2008, the High Level Pharmaceutical Forum agreed on the following
More informationClinical Trials at PMH
Clinical Trials at PMH What You Need To Know UHN Patient Education Improving Health Through Education A Guide for Patients, Their Families and Friends in the PMH Cancer Program This information is to be
More informationCHILDREN'S MENTAL HEALTH ACT
40 MINNESOTA STATUTES 2013 245.487 CHILDREN'S MENTAL HEALTH ACT 245.487 CITATION; DECLARATION OF POLICY; MISSION. Subdivision 1. Citation. Sections 245.487 to 245.4889 may be cited as the "Minnesota Comprehensive
More informationRelated Electronic Written Submissions (
Self-Care This chapter includes the following topics: Delivery of Services and Costs Education and Access to Information The Nurse Line and Phone-Based Health Services The Canada Food Guide The BC Health
More informationProvider Frequently Asked Questions
Provider Frequently Asked Questions Strengthening Clinical Processes Training CASE MANAGEMENT: Q1: Does Optum allow Case Managers to bill for services provided when the Member is not present? A1: Optum
More informationWORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0
WORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0 1 Standard Operating Procedure St Helens CCG Working with The Pharmaceutical Industry Policy Version 1.0 Implementation Date May 2017 Review
More informationThe American Occupational Therapy Association Advisory Opinion for the Ethics Commission Ethical Issues Concerning Payment for Services
The American Occupational Therapy Association Advisory Opinion for the Ethics Commission Ethical Issues Concerning Payment for Services The current health care environment has created the potential for
More informationMonitoring the Mental Health Act
SUMMARY Monitoring the Mental Health Act in 2014/15 There are 57 mental health NHS trusts and 86 independent mental health hospitals registered with CQC. Throughout the year we visit these services to
More informationEmployee Engagement Templates to Help Improve Your Employer Brand
8 Employee Engagement Templates to Help Improve Your Employer Brand Introduction A good employee engagement strategy can help improve your employer brand over time. But it s hard to know how to reach out
More informationExploring Nurses Perceptions of Spiritual Care and Harm Reduction in an Acute Inpatient HIV Unit: A Quality Improvement Perspective
Exploring Nurses Perceptions of Spiritual Care and Harm Reduction in an Acute Inpatient HIV Unit: A Quality Improvement Perspective Opening reflection Now that most people do not have a religious focus,
More informationMoncton Pre-Election Town Hall on Major Health Care Concerns Key Messages
Moncton Pre-Election Town Hall on Major Health Care Concerns Key Messages Background The September 24th provincial election provides an excellent opportunity for New Brunswickers to raise issues to politicians
More informationCentral Australian Aboriginal Congress Aboriginal Corporation Position Description
Central Australian Aboriginal Congress Aboriginal Corporation Position Description POSITION DIVISION BASE LEVEL & SALARY LOCATION CLINICAL PSYCHOLOGIST (PN725) HEALTH SERVICES DIVISION - SEWB Level 10/1
More informationVENDOR RELATIONS POLICY TRAINING
VENDOR RELATIONS POLICY TRAINING INTRODUCTION Vendor Relations Policy Key Points All employees of the University of California are subject to the conflict-of-interest provisions of the Political Reform
More informationConnecting Therapy to Outcome and Process Measures: Moving from Concept to Reality
Connecting Therapy to Outcome and Process Measures: Moving from Concept to Reality Presented By: Cindy Krafft MS PT Director of Rehabilitation Consulting Services President Home Health Section APTA August
More informationManaging Violence and Aggression in CAMHS. QNIC May 26 th 2011.
Managing Violence and Aggression in CAMHS. QNIC May 26 th 2011. Ian Higgins, Nurse Consultant for Safeguarding Children, S.W.London & St George s Mental Health Trust. Aims of the Workshop Review the current
More informationPOLICY TYPE I ENDS Revised: March 2016
POLICY TYPE I ENDS Revised: March 2016 ENDS POLICIES TABLE OF CONTENTS Overview...1 E 1 Strategic Priorities...3 E2 Foundational Pillars...4 E Overview CARNA exists so that: The Alberta public is assured
More informationTHE POWER OF & Patient Experience is. Jason A. Wolf, PhD, CPXP President, The #PX2017 March 20, 2017
Patient Experience is THE POWER OF & Jason A. Wolf, PhD, CPXP President, The Beryl Institute @jasonawolf @berylinstitute #PX2017 March 20, 2017 Patient Experience is THE POWER OF & Reaching Beyond the
More informationOn Pins & Needles: Caregivers of Adults with Mental Illness
On Pins & Needles: Caregivers of Adults with Mental Illness Rick Greene, National Alliance for Caregiving International Carers Conference, Adelaide, Australia 1 Report Sponsors This research was made possible
More informationNovel drug development gets an impetus when academia, SME s and global companies combine their strengths. Clinical. Clinical Phase IIa.
SME Partnership Call Jon de Vlieger & Jorg Janssen April 17, 2012 This presentation has been used during the information session on April 17. The Info Sheet document, version April 20, 2012, contains the
More informationElectronic Prescribing Medicine Administration (epma)
Electronic Prescribing Medicine Administration (epma) Christine Walters Director of IM&T The Pennine Acute Hospitals NHS Trust 10 th July 2013 How to get IM&T to be seen as a benefit not just a cost Example
More informationYour guide to gifts in Wills. Every family that needs one should have an Admiral Nurse
Your guide to gifts in Wills Every family that needs one should have an Admiral Nurse We can help carers find solutions to the challenges they face. Sarah Hiscocks, Admiral Nurse A gift in your Will could
More informationWelcome to the first of a four part series on Early Childhood Intervention and Medicaid managed care. Throughout the four parts, you will learn about
Welcome to the first of a four part series on Early Childhood Intervention and Medicaid managed care. Throughout the four parts, you will learn about Texas Medicaid Managed Care, Texas Early Childhood
More informationFrom Free Drug to Paid Prescriptions: PATIENT ASSISTANCE STRATEGIES TO ENSURE ROI. by Jan Nielsen, Division President, SonexusHealth
From Free Drug to Paid Prescriptions: PATIENT ASSISTANCE STRATEGIES TO ENSURE ROI by Jan Nielsen, Division President, SonexusHealth The Role of Patient Assistance Programs Healthcare affordability is reaching
More informationAcurian on. Patient Attrition in Clinical Trial Enrollment. Is There an Awareness Issue?
Acurian on Patient Attrition in Clinical Trial Enrollment Why does it seem so hard to recruit patients for a trial outside of my selected clinical site practices? This is a question that Patient Recruitment
More informationOncology Pharmacy Services
Oncology Pharmacy Services Your partner in patient-centered care Supporting you and your patients You want to focus on patient care, not paperwork. So you need an oncology pharmacy that does more than
More informationExecutive Job Codes and Descriptions
Executive Job Codes and Descriptions Please note: The Executive Compensation Survey is designed to collect information on the highest level jobs reporting directly to the CEO, and/or jobs considered part
More informationTakeda akeda Research esearch Investment, Inc. nc. 435 Tasso Street, Suite 300 Palo Alto, CA94301 USA. Tel: +1 (650)
Takeda akeda Research esearch Investment, Inc. nc. 435 Tasso Street, Suite 300 Palo Alto, CA94301 USA Tel: +1 (650) 328 2900 www.tri-takeda.com 2 3 4 5 www.tri-takeda.com Operations started April 2002
More informationSASKATCHEWAN ASSOCIATIO. RN Specialty Practices: RN Guidelines
SASKATCHEWAN ASSOCIATIO N RN Specialty Practices: RN Guidelines July 2016 2016, Saskatchewan Registered Nurses Association 2066 Retallack Street Regina, SK S4T 7X5 Phone: (306) 359-4200 (Regina) Toll Free:
More informationTHE ANDREW MARR SHOW INTERVIEW: SIMON STEVENS 22 ND MAY 2016
1 THE ANDREW MARR SHOW INTERVIEW: SIMON STEVENS 22 ND MAY 2016 Andrew Marr: Before we get going I don t normally do this but I think people should just see a graph which shows the huge amount of red streaking
More informationTransforming Kidney Transplants in the West Midlands
Transforming Kidney Transplants in the West Midlands In 2015, the West Midlands region had some of the longest waiting times for kidney transplants in the UK. The chances of a patient getting on the kidney
More informationSolution Title Impact on readmission rates of psychiatric patients following pharmacist discharge counseling in a community hospital
Organization Suburban Hospital Johns Hopkins Medicine Solution Title Impact on readmission rates of psychiatric patients following pharmacist discharge counseling in a community hospital Program/Project
More informationInformation for Staff. Guidelines for Communicating Bad News with Patients and their Families
Information for Staff Guidelines for Communicating Bad News with Patients and their Families March 2006 COMMUNICATING BAD NEWS WITH PATIENTS AND THEIR FAMILIES INTRODUCTION As health care professionals
More informationRemarks by Russell Williams President Canada s Research-Based Pharmaceutical Companies Rx&D. Canadian Clinical Trials Summit
Remarks by Russell Williams President Canada s Research-Based Pharmaceutical Companies Rx&D Canadian Clinical Trials Summit September 15, 2011 Ottawa, Ontario Check against delivery Thank you Wayne, Today
More informationCoordinated cancer care: better for patients, more efficient. Background
the voice of NHS leadership briefing June 2010 Issue 203 Coordinated cancer care: Key points There are two million people with cancer in the UK. It is suggested that by 2030 there will be over four million
More informationAPPENDIX B. Physician Assistant Competencies: A Self-Evaluation Tool
APPENDIX B Physician Assistant Competencies: A Self-Evaluation Tool Rate your strength in each of the competencies using the following scale: 1 = Needs Improvement 2 = Adequate 3 = Strong 4 = Very Strong
More informationCCG Policy for Working with the Pharmaceutical Industry
CCG Policy for Working with the Pharmaceutical Industry 1. Introduction Medicines are the most frequently and widely used NHS treatment and account for over 12% of NHS expenditure. The Pharmaceutical Industry
More informationQuality Improvement Plan (QIP) Narrative for Health Care Organizations in Ontario
Quality Improvement Plan (QIP) Narrative for Health Care Organizations in Ontario 3/16/2016 This document is intended to provide health care organizations in Ontario with guidance as to how they can develop
More informationCare Programme Approach (CPA)
Care Programme Approach (CPA) The Care Programme Approach (CPA) is a package of care that may be used to plan your mental health care. This factsheet explains what CPA is, when you should get and when
More informationATTACHMENT I. Outpatient Status: Solicitation of Public Comments
ATTACHMENT I The following text is a copy of the Federation of American Hospitals ( FAH ) comments in response to the solicitation of public comments on outpatient status that was contained in CMS-1589-P;
More informationSolution Title: Population Health: A Paradigm Shift in how we care for Behavioral Health Patients
Solution Title: Population Health: A Paradigm Shift in how we care for Behavioral Health Patients Overview of Project A drive to Population Health and changes in reimbursement have prompted the need to
More information